Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Taysha Gene Therapies, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- −2 vs. Q1 2024
- Shares held
- 158.2M
- +18.0M (+12.8%) vs. Q1 2024
- Total value
- $354.3M
- −$47.9M (−11.9%) vs. Q1 2024
- New holders
- 36
- 29 more added
- Sold out
- 38
- 21 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $2.03B |
| Q1 2026 | 191 | $1.18B |
| Q4 2025 | 195 | $1.48B |
| Q3 2025 | 155 | $865.6M |
| Q2 2025 | 150 | $595.4M |
| Q1 2025 | 127 | $232.0M |
| Q4 2024 | 131 | $289.8M |
| Q3 2024 | 119 | $315.5M |
| Q2 2024 | 107 | $354.3M |
| Q1 2024 | 109 | $402.2M |
| Q4 2023 | 87 | $230.3M |
| Q3 2023 | 63 | $410.6M |
| Q2 2023 | 39 | $9.05M |
| Q1 2023 | 44 | $13.3M |
| Q4 2022 | 52 | $43.8M |
| Q3 2022 | 54 | $27.0M |
| Q2 2022 | 59 | $54.7M |
| Q1 2022 | 71 | $110.9M |
| Q4 2021 | 65 | $215.6M |
| Q3 2021 | 48 | $361.9M |
| Q2 2021 | 49 | $388.6M |
| Q1 2021 | 46 | $358.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 7,477,397 | $16.7M | 0.00% | +2,308,507+44.7% | Added |
| VR Adviser, LLC | 9,000,000 | $20.2M | 1.28% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 10,872,503 | $24.4M | 0.32% | 00.0% | Unchanged |
| BlackRock Inc. | 11,742,449 | $26.3M | 0.00% | +9,145,146+352.1% | Added |
| Avoro Capital Advisors LLC | 18,650,000 | $41.8M | 0.56% | 00.0% | Unchanged |
| RTW Investments, LP | 18,800,299 | $42.1M | 0.65% | +207,114+1.1% | Added |
| FMR LLC | 21,210,636 | $47.5M | 0.00% | +1,099,919+5.5% | Added |
| Eversept Partners, LP | 0 | $0 | 0.00% | −2,325,591−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −1,550,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,113,232−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −1,087,785−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −925,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −414,980−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −220,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −188,698−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −181,306−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −172,769−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −164,258−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −161,100−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −122,905−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −121,517−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −112,413−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −112,077−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −110,992−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −97,054−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −76,419−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −61,352−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −54,090−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −41,052−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −32,485−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −29,800−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −28,000−100.0% | Sold out |
| Polymer Capital Management (HK) LTD | 0 | $0 | 0.00% | −27,680−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −26,477−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −24,200−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −17,800−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −14,382−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| TradeLink Capital LLC | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −10,204−100.0% | Sold out |
| Symmetry Investments LP | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −2,315−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −8,066−100.0% | Sold out |